Preliminary Summary of Consolidated Financial Statements for the First Quarter Ended June 30, 2026 (IFRS Basis)

Date: July 28, 2026

Company Representative: Tatsuya Akagi, President

Contact Person: Yasuhiro Iseyama, Senior Executive Vice President, Director of Corporate Accounting & Finance Division Phone: +81-6-7632-2101

Estimated starting date of dividend paying: -Preparation of supplementary explanatory materials: Yes

Holding of quarterly earnings release conference: Yes (for investment analysts and institutional investors)

(All monetary values noted herein are rounded down to the nearest million yen)

1. Consolidated financial results for the three months ended June 30, 2026

   1. Operating results (% of change from same period in the previous year)

      	Revenue		Operating profit		Profit before income taxes		Net profit		Net profit attributable to owners of the parent company		Total comprehensive income
      For the three months ended June 30, 2026 For the three months ended June 30, 2025	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%	Millions of yen	%
      	271,672 246,192	10.3 (1.3)	49,210 42,645	15.4 (15.9)	49,581 43,307	14.5 (14.4)	33,887 31,322	8.2 (13.3)	33,872 31,303	8.2 (13.4)	48,752 27,978	74.3 (60.5)

      	Basic earnings per share	Diluted earnings per share
      	Yen	Yen
      For the three months ended June 30, 2026	50.75	50.73
      For the three months ended June 30, 2025	45.68	45.66

   2. Financial position

      	Total assets	Total equity	Equity attributable to owners of the parent company	Ratio of equity attributable to owners of the parent company to total assets
      	Millions of yen	Millions of yen	Millions of yen	%
      As of June 30, 2026	1,442,604	1,148,232	1,147,147	79.5
      As of March 31, 2026	1,441,757	1,149,103	1,148,027	79.6

2. Dividends

   	Dividends per share
   	1Q	2Q	3Q	Year-end	Annual
   March, 2026 March, 2027	Yen - -	Yen 30.00	Yen -	Yen 30.00	Yen 60.00
   (Forecast) March, 2027		32.00	-	32.00	64.00

   (Note) Revision of dividend forecast in the current quarter: No

3. Forecast for fiscal year ending March 31, 2027

(% of change from same period in the previous year)

(Note) Revision of consolidated forecast in the current quarter: Yes

• Others

  1. Significant changes in the scope of consolidation during the period: No

  2. Changes in accounting policies applied and changes in accounting estimates

     1. Changes in accounting policies required by IFRS: No

     2. Changes in accounting policies other than the above: No

     3. Changes in accounting estimates: No

  3. Number of issued shares (Common stock)

     1. Number of issued shares at the end of the period (including treasury shares)

        As of June 30, 2026: 678,659,700 As of March 31, 2026: 678,659,700

     2. Number of treasury shares at the end of the period

        As of June 30, 2026: 14,437,950 As of March 31, 2026: 4,999,950

     3. Average number of issued shares during the period (cumulative from the beginning of the period) April-June 2026: 667,442,483 April-June 2025: 685,323,967

• Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: Yes (voluntary)

• Explanations for adequate utilization of the forecast and other special matters

The forward-looking statements shown in this report, including the forecast, are prepared based on information available to the Company and on certain assumptions deemed reasonable as of the issuing date of the report. Consequently, the statements herein do not constitute promises regarding actual results by the Company. Actual results may differ materially from forecasted figures due to various unknown factors.

(Reference) Segment Information (Millions of yen)

For the three months ended June 30, 2025

For the three months ended June 30, 2026

Industrial Tape

Optronics

Human Life

Others Adjustment Total

Revenue Revenue Y-o-Y (%)

Revenue 85,780 101,076 117.8

Operating profit 9,871 16,280 164.9

Information Fine Materials 99,528 89,710 90.1

Circuit Materials 31,013 42,489 137.0

Total 130,541 132,199 101.3

Operating profit 36,755 35,375 96.2

Life Science 10,428 15,610 149.7

Membrane 8,596 8,807 102.5

Personal Care Materials 13,450 16,358 121.6

Total 32,476 40,776 125.6

Operating profit (1,630) (317) -

Revenue 3 14 463.9

Operating profit (1,700) (1,843) -

Revenue (2,609) (2,395) -

Operating profit (650) (285) -

Revenue 246,192 271,672 110.3

Operating profit 42,645 49,210 115.4

(Reference) Segment Information (annual forecast) (Millions of yen)

Forecasts of fiscal year ending March 31, 2027

Industrial Tape

Optronics

Human Life

Others Adjustment Total

Revenue Y-o-Y (%)

Revenue 406,000 110.7

Operating profit 66,500 128.7

Information Fine Materials 368,000 95.3

Circuit Materials 178,500 126.1

Total 546,500 103.5

Operating profit 148,000 98.8

Life Science 62,000 114.8

Membrane 37,000 110.7

Personal Care Materials 68,000 120.8

Total 167,000 116.2

Operating profit 1,000 -

Revenue 500 4,254.6

Operating profit (8,000) -

Revenue (10,000) -

Operating profit (7,500) -

Revenue 1,110,000 108.0

Operating profit 200,000 108.9

2. Quarterly Consolidated Financial Statements

(1) Quarterly consolidated statement of financial position

Assets

Current assets

(Millions of yen)

As of March 31, 2026 As of June 30, 2026

-